Domů › Glioblastom › Texas › Houston
Klinické studie Glioblastom v Houston, TX
25 studií pro Glioblastom hledá účastníky v lokalitách v Houston a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Probíhá náborFáze 2/3
- University of Texas - MD Anderson Cancer Center, Houston
GPC-3 CAR T CELLS FOR Recurrent GPC-3 Positive Glioblastoma
Probíhá náborFáze 1
- Baylor St. Luke's Medical Center, Houston
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
Probíhá náborFáze 1
- MD Anderson Cancer Center, Houston
A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
Probíhá náborFáze 1/2
- Baylor College of Medicine, Houston
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
Probíhá náborFáze 1
- M D Anderson Cancer Center, Houston
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Probíhá náborFáze 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Probíhá náborFáze 1
- The University of Texas MD Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
Probíhá náborObservační studie
- Texas Children's Hospital, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
Probíhá náborFáze 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
Probíhá náborFáze 2
- Texas Children's Hospital, Houston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Probíhá náborFáze 3
- MD Anderson Cancer Center, Houston
A Phase1 Clinical Trial Evaluating Locoregional Delivery Of Engineered NK Cells Containing IL13Ra And EGFvIII Chimeric Antigen Receptor (CAR), IL-21 Secretion And Deleted TGF-BetaR2 And NR3C1 In Recurrent Glioblastoma
Probíhá náborFáze 1
- MD Anderson Cancer Center, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
Probíhá náborFáze 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma
Probíhá náborFáze 1/2
- The University of Texas M. D. Anderson Cancer Center, Houston
- The University of Texas MD Anderson Cancer Center, Houston
Customized Neuro-Imaging Referenced Symptom Video for the Reduction of Patient and Caregiver Anxiety Around Radiation Treatment for Brain Tumors
Probíhá náborVítáni zdraví dobrovolníci
- M D Anderson Cancer Center, Houston
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
Probíhá náborFáze 2
- M D Anderson Cancer Center, Houston
DOC1021 Dendritic Cell Immunotherapy for Treatment of Newly Diagnosed Adult Glioblastoma (GBM)
Probíhá náborFáze 2
- UTHealth Houston, Houston
- Baylor College of Medicine, Houston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Probíhá náborRaná fáze 1Vítáni zdraví dobrovolníci
- Texas Children's Hospital, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Probíhá náborFáze 2
- Texas Children's Hospital, Houston
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
Probíhá náborFáze 1/2
- MD Anderson Cancer Center, Houston
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
Probíhá náborFáze 1/2
- Houston Methodist Neurological Institute, Houston
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
Probíhá náborFáze 1/2
- Houston Methodist Neurological Institute, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Probíhá náborObservační studie
- Massive Bio SYNERGY-AI site, Houston
A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
Probíhá náborFáze 1/2
- MD Anderson Cancer Center, Houston
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
Probíhá náborFáze 1
- UT MD Anderson Cancer Center, Houston
Studie Glioblastom v jiných městech
- New York City, NY30 studií
- Boston, MA28 studií
- Los Angeles, CA23 studií
- Durham, NC20 studií
- San Francisco, CA17 studií
- Washington, DC15 studií
- Chicago, IL15 studií
- Rochester, MN15 studií
- Columbus, OH14 studií
- Miami, FL14 studií
- Jacksonville, FL13 studií
- Aurora, CO12 studií
Další studie v Houston
- Nemalobuněčný plicní karcinom145 studií
- Rakovina prsu126 studií
- Rakovina (všechny typy)121 studií
- Metastatický karcinom104 studií
- Kolorektální karcinom102 studií
- Rakovina vaječníků89 studií
- Akutní myeloidní leukemie85 studií
- Rakovina plic78 studií
- Rakovina prostaty76 studií
- Rakovina endometria68 studií
- Rakovina slinivky břišní61 studií
- Melanom59 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.